Form 8-K SYNERGY PHARMACEUTICALS, For: May 16
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/21/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall Street sinks as bond yields rise, Walmart results disappoint
- Supermicro probe finds no senior management link to export violations
- Wolfe remains "broadly bullish on AI semis stocks", names Top Pick
- Hertz Global amends voting agreement with CK Amarillo after lawsuit
Synergy Pharma (SGYP) Gains as Paulson & Co. Loads Up
May 17, 2016 9:25 AM EDTSynergy Pharma (NASDAQ: SGYP) is gaining in pre-open trade after John Paulson's, Paulson & Co, disclosed that it owned 27,756,668 shares as of 05/04/16, according to a new Form 4 filing.
This is up from the 9,000,000 shares held at the end of the year 2016 and the 11,090,000... More
